Why Corcept Therapeutics stock crashed today and what comes next?
Corcept Therapeutics (NASDAQ: CORT) crashed about 50% on Dec. 31 after the FDA requested additional data to support the efficacy of relacorilant,
Corcept Therapeutics (NASDAQ: CORT) crashed about 50% on Dec. 31 after the FDA requested additional data to support the efficacy of relacorilant,
On December 1st, famed investor Jim Cramer looked into the camera on CNBC’s Mad Money and made a provocative statement – “maybe
Analysts increasingly believe Microsoft could reach a $5 trillion market valuation in early 2026.The analysis is driven by accelerating artificial intelligence monetisation,
Tesla stock was mostly flat on Wednesday, the final trading day of 2025, capping a turbulent year marked by sharp swings in
The “Dogs of the Dow” strategy has staged a comeback, and Kevin Simpson of Capital Wealth Planning believes 2026 could be another
European markets and politics closed the year on sharply diverging trajectories.London stocks delivered their strongest performance since the financial crisis, while geopolitical
Markets are looking to kick off the year with a volatile mix of tech, geopolitics, speculative finance, and protectionism.Nvidia is racing to
Boeing (NYSE: BA) had a strong 2025, and hedge fund manager Dan Niles expects the stock to keep climbing into next year.In
Markets are closing the year with a shift in tone.Tonight’s digest tracks a cooling tech rally, a landmark energy-tech spinoff, and volatility
Europe is discovering how quickly narratives can flip markets, diplomacy, and domestic politics.A few words about peace from Washington were enough to